Chapter 6 : Dreams about Vaccines

MyBook is a cheap paperback edition of the original book and will be sold at uniform, low price.

Preview this chapter:
Zoom in

Dreams about Vaccines, Page 1 of 2

| /docserver/preview/fulltext/10.1128/9781555817428/9781555815158_Chap06-1.gif /docserver/preview/fulltext/10.1128/9781555817428/9781555815158_Chap06-2.gif


A malaria vaccine, discounted for decades during the “eradication era,” became the possible dream when in 1961 researchers found that IgG from immune Gambian adults had an antiparasitic effect when administered to children infected with . Despite all the experimental efforts with birds and monkeys, the fact remained that, after half a century, a protective malaria vaccine was not on the horizon. At a minimum, a vaccine for human use would require an immunogen that could be prepared in large amounts in a reproducible manner and would be free of microbial and host cell contaminants, pyrogens, toxins, and other potentially dangerous antigens. The desirable vaccine would have to remain stable over a reasonably long period; its potency would have to be measured in terms of efficacy in vivo and/or in vitro; and it would have to be efficacious in an appropriate animal model before being used in humans. As a researcher said, manipulation of what is essentially an autoimmune reaction would require special care.

Citation: Sherman I. 2009. Dreams about Vaccines, p 111-130. In The Elusive Malaria Vaccine. ASM Press, Washington, DC. doi: 10.1128/9781555817428.ch6
Highlighted Text: Show | Hide
Loading full text...

Full text loading...



This is a required field
Please enter a valid email address
Please check the format of the address you have entered.
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error